JS

Jake Simson

Partner at RA Capital Management

Cambridge, Massachusetts

Overview

Work Experience

  • Partner

    2020 - Current

  • Principal

    2017 - 2020

  • Analyst

    2015 - 2017

  • Associate

    2013 - 2015

  • PhD Candidate

    2008 - 2013

    - Developed and optimized a novel biological adhesive hydrogel for meniscal and cartilage tissue repair - Evaluated the potential of biologic hydrogels to regenerate bone and cartilage in a pre-clinical large animal model as a critical step to seeking funding for clinical translation - Collaborated with clinicians to develop endoscopic delivery protocol of a tissue adhesive to prevent scarring in gastroenterological and otolaryngological applications - Mentored seven undergraduate or visiting students in biomaterial development and regenerative medicine techniques

  • Collaborating Researcher

    2010 - 2010

    Developed a fully biologic hydrogel carrier to deliver and localize recombinant human bone morphogenetic protein-2 to enhance musculoskeletal tissue repair

  • Visiting Research Associate

    2009 - 2009

    Provided technical support for data collection and analysis leading to approval of ChondroCelect®, the first cell therapy approved by the European Medicines Agency

  • Undergraduate Research Associate

    2006 - 2008

    - Identified and analyzed the distribution of lubricin in samples of human intervertebral disc using immunohistochemistry techniques to determine the source and role of this protein in disc function - Synthesized and characterized collagen-GAG hybrid scaffolds for use in nucleus pulposus regeneration using human mesenchymal stem cells

Relevant Websites